7.1. Drugs used in obstetrics
7.1.1. Prostaglandins and oxytocics
7.1.1.1. Drugs affecting the ductus arteriosus
7.1.2. Mifepristone

Restrictions:
Restricted to specialist use only.
Prescribing Notes:
The combined pack presentation of mifepristone and misoprostol (Medabon®) remains non-Formulary.
It offered no advantage over existing formulary choices and was considered to introduce additional risk. This presentation will not be stocked in relevant departments in NHSGGC.
7.1.3. Myometrial relaxants

Restrictions: Restricted to specialist initiation.
Prescribing Notes:
The licensed preparation of ritodrine has been discontinued. An unlicensed preparation of ritodrine is currently used within obstetrics